The challenge of building a new strategy
Despite our excitement, despite our proven clinical success, we must remember that we are still at the beginning of a new era in stroke care. It is of critical importance that each of us, in our specific capacities as individual specialists, confront the various questions that remain unanswered and that impinge on the efficacity of our therapeutic approach. To advance and build strong foundations for care, an open exchange of our clinical experience and sharing our ongoing research and therapeutic strategies can help us develop – together – a new paradigm for stroke care and its management.
The very trials that “consecrated” mechanical thrombectomy (MT) also clearly underline the integrated role of lithics in the overall success of this treatment. However, questions continue to emerge as to the correct use – the when, why and how – of these lithics; questions whose answers are critical for the overall success of the care we offer.
- What unified approach, if any, should be taken to the use of lithics?
- Should we choose immediate thrombolysis or decide instead to go directly to MT?
- Should one be done before the other…or not at all?
- Is an aggressive use of lithics the next step in our care strategy, and what does that imply?
The debate is very real, and SLICE is designed to be the perfect theater for this debate to take place.
It is only by dialoging openly and together that neurologists and neuro-interventionists can develop a consensus approach that makes sense for all of us and, above all, for our patients. We look forward to your presence, and above all, your participation in Nice – Guidelines need to be forged from our common concerns and we can – and will – do this together in October.
To learn more about this subject, attend the following session :
Tuesday, October 2, 2018 – 08:15 – 09:10
Redefining the Synergistic Approach of lithics and mechanics
Speakers Jan GRALLA (Bern, SWITZERLAND), Ralph WEBER (Essen, GERMANY)
Predictors of post-alteplase recanalization in stroke referrals for thrombectomy; and recanalization with tenecteplase versus alteplase
Speaker Pierre SENERS (Paris, FRANCE)